Stock News
XOMA Royalty Announces Quarterly Dividends for Preferred Stock
XOMA Royalty Corporation Announces Dividend Declaration Emeryville, Calif., September 23, 2024 XOMA Royalty Corporation (Nasdaq: XOMA) has made an exciting announcement today regarding cash dividends for holders of XOMA’s Series A and Series B Cumulative Preferred Stock. Details of Dividend Declaration: The Board of Directors has authorized the following cash dividends: Holders of the 8.625%…
Score! Neotech Metals Corp. Gets the Green Light for $200K Grant in Ontario Exploration Program
Exploring Ontario’s Mineral Resources with Neotech Metals Corp. Discovering the Green Transition, One Grant at a Time Hold onto your hockey sticks, maple syrup lovers! Neotech Metals Corp. is making waves in the exploration world with their recent approval by the Ontario Junior Exploration Program (OJEP). This exciting news means that Neotech will receive $200,000…
Nasdaq Expands Digital Bank and FinTech Presence in Latin America
Expanded Partnership with Nubank Reflects Rapid Growth of Banking and Payment Services in Latin America Introduction Over half of Nasdaq’s Latin American banking clients have expanded their technology partnership in the last 12 months. Nasdaq’s financial technology solutions simplify regulatory compliance and reduce time to market across multiple jurisdictions. New Partnership with Nubank New York…
Clever Collaboration: Nicox and Glaukos Join Forces for NCX-1728 Research and Global Licensing
Nicox and Glaukos sign exclusive research and licensing agreement Clever, personable, and wonderfully unconventional, yet reader-friendly, the recent agreement between Nicox and Glaukos has created quite a stir in the world of ophthalmology. The two companies have signed an exclusive research and license option agreement for NCX 1728, Nicox’s novel nitric oxide-donating phosphodiesterase-5 inhibitor. What…
Breaking News: FDA Clears Innate Pharma’s IND for IPH4502, a Promising Treatment for Solid Tumors
Exciting Development in Cancer Treatment: Innate Pharma Receives FDA Clearance for Phase 1 Study Marseille, France (BUSINESS WIRE) Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) announced today that the U.S Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to initiate a Phase 1 clinical study of IPH4502, its novel…
Title: Investor Alert: Securities Fraud Class Action Lawsuit Filed Against Lululemon Athletica Inc.
The Impact of the Securities Class Action Lawsuit Against lululemon athletica inc. RADNOR, Pa., Sept. 22, 2024 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against…
Uncovering the Power of Accesswire: A Must-Read for Bloggers and Readers
Investors Alerted to Securities Class Action Lawsuit Against Methode Electronics, Inc. RADNOR, PA / ACCESSWIRE / September 22, 2024 The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Methode Electronics,…
Telix Takes on RLS: A Strategic Move to Strengthen Manufacturing and Distribution in North America
Telix Pharmaceuticals Announces Acquisition of RLS Radiopharmacies On September 23, 2024, Telix Pharmaceuticals Limited and RLS (USA) Inc. revealed a groundbreaking agreement that will see Telix acquire RLS Radiopharmacies from its parent company, RLS Group Ltd. This acquisition is a significant move that will greatly enhance Telix’s presence in North America, particularly in the manufacturing…